Darren S Cline
CIK 1633639 · Chief Commercial Officer · last filed 2026-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$442.5K
Companies
7
Total Filings
51
Lifetime Open-Market Net
-$5.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Director | 251,405 | $1.76 | $442.5K | $93.9K | 7 | 2026-03-25 |
| XENE | Chief Commercial Officer | — | $52.10 | — | $0 | 2 | 2026-01-09 |
| PLRX | Director | — | $1.13 | — | $0 | 4 | 2025-06-09 |
| IPI Legacy Liquidation Co (IMPL) Delisted | Director | — | $0.24 | — | $0 | 2 | 2023-06-20 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | U.S. Chief Commercial Officer | 5,556 | $218.96 | $1.22M | $0 | 5 | 2021-03-04 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Director | 0 | — | — | $0 | 3 | 2020-06-10 |
| Seagen Inc. (SGEN) Delisted | EVP, Commercial | 72,556 | $228.74 | $16.60M | -$5.46M | 27 | 2018-11-30 |
Recent Filings · Page 2 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-28 | PYXS | Grant (A) | +139,355 | $0 | EDGAR |
| 2023-03-08 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | PYXS | Grant (A) | +66,831 | $0 | EDGAR |
| 2021-12-09 | PYXS | Buy (P) | +10,000 | $93.9K | EDGAR |
| 2021-10-12 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | — | Disp (D) | −5,556 | $0 | |
| 2021-03-04 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-24 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | U | −35,468 | $0 | EDGAR |
| 2020-06-08 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.